Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Varian Particle Therapy. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy. Its products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, and accessories; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, oncology practices, radiotherapy centers, and cancer care clinics. The Varian Particle Therapy segment develops, designs, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. Varian Medical Systems, Inc. has a strategic partnership with Siemens AG to co-develop new imaging and treatment solutions. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:VAR
CUSIP92220P10
Phone650-493-4000
Debt
Debt-to-Equity RatioN/A
Current Ratio1.53
Quick Ratio1.25
Price-To-Earnings
Trailing P/E Ratio32.34
Forward P/E Ratio25.98
P/E Growth3.24
Sales & Book Value
Annual Sales$2.67 billion
Price / Sales3.99
Cash Flow$4.4963 per share
Price / Cash25.89
Book Value$16.33 per share
Price / Book7.13
Profitability
EPS (Most Recent Fiscal Year)$3.60
Net Income$249.60 million
Net Margins4.77%
Return on Equity27.99%
Return on Assets12.51%
Miscellaneous
Employees6,600
Outstanding Shares91,500,000
Market Cap$10,632.85
Varian Medical Systems (NYSE:VAR) Frequently Asked Questions
What is Varian Medical Systems' stock symbol?
Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."
How were Varian Medical Systems' earnings last quarter?
Varian Medical Systems, Inc. (NYSE:VAR) announced its earnings results on Wednesday, April, 25th. The medical equipment provider reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.04 by $0.11. The medical equipment provider earned $729.90 million during the quarter, compared to the consensus estimate of $685.86 million. Varian Medical Systems had a net margin of 4.77% and a return on equity of 27.99%. The firm's revenue for the quarter was up 10.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.89 EPS. View Varian Medical Systems' Earnings History.
When is Varian Medical Systems' next earnings date?
What guidance has Varian Medical Systems issued on next quarter's earnings?
Varian Medical Systems issued an update on its FY18 earnings guidance on Wednesday, April, 25th. The company provided earnings per share guidance of $4.43-4.53 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.40. The company issued revenue guidance of +6-9% (Approx $3.11-3.21 billion), compared to the consensus revenue estimate of $2.79 billion.
What price target have analysts set for VAR?
8 brokerages have issued 12 month target prices for Varian Medical Systems' shares. Their predictions range from $98.00 to $132.00. On average, they anticipate Varian Medical Systems' share price to reach $111.2857 in the next twelve months. This suggests that the stock has a possible downside of 4.4%. View Analyst Ratings for Varian Medical Systems.
What is the consensus analysts' recommendation for Varian Medical Systems?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Varian Medical Systems in the last year. There are currently 3 sell ratings, 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
Who are some of Varian Medical Systems' key competitors?
Some companies that are related to Varian Medical Systems include SONOVA Hldg AG/ADR (SONVY), Masimo (MASI), LivaNova (LIVN), GETINGE AB/ADR (GNGBY), CONMED (CNMD), AxoGen, Inc Common Stock (AXGN), NxStage Medical (NXTM), Natus Medical (BABY), Viewray (VRAY), Cutera (CUTR), Electrocore (ECOR), BioLife Solutions (BLFS), Rockwell Medical (RMTI), Vision Sciences (CGNT) and Helius Medical Technologies (HSDT).
Who are Varian Medical Systems' key executives?
Varian Medical Systems' management team includes the folowing people:
- Mr. Gary E. Bischoping Jr., Sr. VP of Fin. & CFO (Age 50)
- Mr. Dow R. Wilson, Pres, CEO & Director (Age 59)
- Mr. Patrick Joda, Sr. VP of Global Operations (Age 60)
- Mr. Magnus A. Momsen, Sr. VP, Chief Accounting Officer & Corp. Controller
- Mr. Corey Zankowski Ph.D., Chief Technology Innovation Officer and Sr. VP
Has Varian Medical Systems been receiving favorable news coverage?
News stories about VAR stock have trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Varian Medical Systems earned a news sentiment score of 0.08 on Accern's scale. They also assigned media stories about the medical equipment provider an impact score of 44.95 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
Who are Varian Medical Systems' major shareholders?
Varian Medical Systems' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Alecta Pensionsforsakring Omsesidigt (1.74%), Oakbrook Investments LLC (0.36%), Saratoga Research & Investment Management (0.30%), Hardman Johnston Global Advisors LLC (0.23%), Bank of Montreal Can (0.11%) and Montrusco Bolton Investments Inc. (0.10%). Company insiders that own Varian Medical Systems stock include Clarence R Verhoef, David J Illingworth, Dow R Wilson, Elisha W Finney, John W Kuo, Kolleen T Kennedy, Magnus Momsen, Mark R Laret, R Andrew Eckert, Susan L Bostrom and Timothy E Guertin. View Institutional Ownership Trends for Varian Medical Systems.
Which major investors are selling Varian Medical Systems stock?
VAR stock was sold by a variety of institutional investors in the last quarter, including Alecta Pensionsforsakring Omsesidigt, Saratoga Research & Investment Management, State of Alaska Department of Revenue, Hardman Johnston Global Advisors LLC, Hartford Investment Management Co., Meag Munich Ergo Kapitalanlagegesellschaft MBH, TNB Financial and LS Investment Advisors LLC. Company insiders that have sold Varian Medical Systems company stock in the last year include David J Illingworth, Dow R Wilson, John W Kuo, Kolleen T Kennedy, Magnus Momsen, Mark R Laret, R Andrew Eckert, Susan L Bostrom and Timothy E Guertin. View Insider Buying and Selling for Varian Medical Systems.
Which major investors are buying Varian Medical Systems stock?
VAR stock was purchased by a variety of institutional investors in the last quarter, including Bank of Montreal Can, DnB Asset Management AS, Nisa Investment Advisors LLC, Calamos Advisors LLC, Montrusco Bolton Investments Inc., Clinton Group Inc., Cohen Klingenstein LLC and Welch & Forbes LLC. View Insider Buying and Selling for Varian Medical Systems.
How do I buy shares of Varian Medical Systems?
Shares of VAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Varian Medical Systems' stock price today?
One share of VAR stock can currently be purchased for approximately $116.41.
How big of a company is Varian Medical Systems?
Varian Medical Systems has a market capitalization of $10.63 billion and generates $2.67 billion in revenue each year. The medical equipment provider earns $249.60 million in net income (profit) each year or $3.60 on an earnings per share basis. Varian Medical Systems employs 6,600 workers across the globe.
How can I contact Varian Medical Systems?
Varian Medical Systems' mailing address is 3100 Hansen Way, Palo Alto CA, 94304. The medical equipment provider can be reached via phone at 650-493-4000 or via email at [email protected]
MarketBeat Community Rating for Varian Medical Systems (NYSE VAR)
MarketBeat's community ratings are surveys of what our community members think about Varian Medical Systems and other stocks. Vote "Outperform" if you believe VAR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VAR will underperform the S&P 500 over the long term. You may vote once every thirty days.
